Biggest News Aggregation in the World
📰 Nasdaq Edit News

Page 4 - Nasdaq Edit News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Edit. Real-time updates on events, politics, business and more.

Editas Medicine (NASDAQ:EDIT) Releases Quarterly Earnings Results, Beats Estimates By $0.20 EPS

Editas Medicine (NASDAQ:EDIT – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.76) by $0.20, Briefing.com reports. The business had revenue of $2.89 million during the quarter, compared to analysts’ expectations of $4.17 million. Editas Medicine had […]
Baisong Mei Gilmore Neil Oneill Raymond James Covestor Ltd Great West Life Assurance Co Sigma Securities

Editas Medicine (NASDAQ:EDIT) Announces Quarterly Earnings Results, Beats Estimates By $0.20 EPS

Editas Medicine (NASDAQ:EDIT – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.76) by $0.20, Briefing.com reports. The firm had revenue of $2.89 million for the quarter, compared to the consensus estimate of $4.17 million. Editas Medicine had a negative net […]
Raymond James Gilmore Neil Oneill Baisong Mei Koss Olinger Consulting Penserra Capital Management Covestor Ltd
Source: wkrb13.com

Editas Medicine (NASDAQ:EDIT) Posts Quarterly Earnings Results, Beats Expectations By $0.20 EPS

Editas Medicine (NASDAQ:EDIT – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.56) EPS for the quarter, beating analysts’ consensus estimates of ($0.76) by $0.20, Briefing.com reports. Editas Medicine had a negative net margin of 960.70% and a negative return on equity of 56.20%. The business had revenue of $2.89 million […]
United States Baisong Mei Gilmore Neil Oneill Raymond James Securities Exchange Commission B Riley Wealth Advisors Inc

Gilmore Neil O'neill Sells 6,486 Shares of Editas Medicine, Inc. (NASDAQ:EDIT) Stock

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) CEO Gilmore Neil O’neill sold 6,486 shares of the stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $9.50, for a total value of $61,617.00. Following the sale, the chief executive officer now directly owns 130,169 shares in […]
Jennifera Doudna Feng Zhang Gilmore Neil Oneill Mercer Global Advisors Inc Royal Bank Wells Fargo Company

Editas Medicine, Inc. (NASDAQ:EDIT) Given Consensus Recommendation of "Hold" by Analysts

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) has been given a consensus rating of “Hold” by the fifteen research firms that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and four have issued a buy recommendation on the company. The […]
Jennifera Doudna Gilmore Neil Oneill Feng Zhang Covestor Ltd Allspring Global Investments Holdings Wells Fargo Company
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Silicon Hills Wealth Management LLC Invests $89,000 in Editas Medicine, Inc. (NASDAQ:EDIT)

Silicon Hills Wealth Management LLC acquired a new position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 10,000 shares of the company’s stock, valued at approximately $89,000. Other large investors also recently made changes […]
Gilmore Neil Oneill Feng Zhang Jennifera Doudna Barclays Plc Securities Exchange Commission Silicon Hills Wealth Management
Source: wkrb13.com

Editas Medicine, Inc. (NASDAQ:EDIT) CEO Gilmore Neil O'neill Sells 6,486 Shares

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) CEO Gilmore Neil O’neill sold 6,486 shares of Editas Medicine stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $9.50, for a total transaction of $61,617.00. Following the completion of the transaction, the chief executive officer now owns […]
Gilmore Neil Oneill Feng Zhang Jennifera Doudna Editas Medicine Inc Great West Life Assurance Co Wells Fargo Company

Editas Medicine, Inc. (NASDAQ:EDIT) Shares Sold by Shelton Capital Management

Shelton Capital Management decreased its holdings in Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) by 7.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 135,200 shares of the company’s stock after selling 10,200 shares during the quarter. Shelton Capital Management owned about 0.20% of […]
Nova Scotia Jennifera Doudna Feng Zhang Blackrock Inc Royal Bank Wells Fargo Company

Editas Medicine (NASDAQ:EDIT) Stock Price Up 7.4%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) rose 7.4% on Tuesday . The company traded as high as $10.29 and last traded at $10.14. Approximately 564,583 shares were traded during mid-day trading, a decline of 69% from the average daily volume of 1,815,854 shares. The stock had previously closed at $9.44. Wall Street Analysts Forecast […]
Feng Zhang Jennifera Doudna George Mcdonald Church Financial Services Group Inc Wells Fargo Company Metlife Investment Management
Source: wkrb13.com

Short Interest in Editas Medicine, Inc. (NASDAQ:EDIT) Grows By 7.3%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 20,230,000 shares, an increase of 7.3% from the April 30th total of 18,860,000 shares. Based on an average trading volume of 1,840,000 shares, the days-to-cover ratio is […]
Nova Scotia Feng Zhang Jennifera Doudna Millennium Management George Mcdonald Church Blackrock Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science